Please find enclosed herewith the Disclosures under Regulation 30 read with Clause 7 pa para of part A of Schedule III of the SEBI (LODR) , Regulation 2015. Regarding the appointment of ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Colinz Laboratories Ltd has appointed Mrs. Vijaya Mani (DIN: 11363910) as an Additional Director in the Non-Executive Non-Independent Director category, effective 11th November 2025. Her appointment will remain valid until the forthcoming Annual General Meeting (40th AGM), subject to shareholder approval under Section 161 of the Companies Act, 2013 and SEBI LODR Regulation 17(1C). Mrs. Vijaya Mani is a BA Graduate with experience in administration, banking, and pharmaceuticals, which the company believes will support its growth. The filing confirms she is not related to any existing director and has not been debarred by SEBI or any other authority.
This is a routine board-level addition that brings in someone with pharma sector exposure, potentially adding administrative and banking expertise to the board. It is unlikely to have a material impact on the stock price as it does not alter control or strategy.